Planned sale of 19,500 shares in KTOS (NASDAQ: KTOS) filing disclosure

Rhea-AI Filing Summary

An affiliate of KTOS filed a Form 144 indicating an intent to sell up to 19,500 shares of common stock through Morgan Stanley Smith Barney, with an indicated aggregate market value of $2,369,250.00. The filing notes that 168,840,708 shares of the issuer’s common stock were outstanding and lists an approximate sale date of 01/15/2026 on the NASDAQ.

The shares to be sold were acquired from the issuer as 13,000 restricted stock units on 01/04/2024 and 6,500 performance stock units on 02/28/2025. The notice also reports that during the past three months there were 10b5-1 sales for Phillip Carrai of 6,000 common shares on 12/15/2025, generating $455,451.18 in gross proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19500	2369250.00	168840708	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/04/2024	Restricted Stock Units	Issuer			13000	01/04/2024	N/A
Common	02/28/2025	Performance Stock Units	Issuer			6500	02/28/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PHILLIP CARRAI 10680 TREENA STREET, SUITE 600 SAN DIEGO CA 92131	Common	12/15/2025	6000	455451.18

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the KTOS Form 144 filing disclose?

The Form 144 for KTOS discloses a planned sale of up to 19,500 shares of common stock, with an indicated aggregate market value of $2,369,250.00, to be executed through Morgan Stanley Smith Barney on the NASDAQ.

How many KTOS shares are planned for sale under this Form 144?

The filing indicates an intent to sell up to 19,500 shares of KTOS common stock, with an approximate sale date of 01/15/2026, and notes that the shares are expected to trade on the NASDAQ.

When and how were the KTOS shares in this Form 144 acquired?

The securities to be sold were acquired from the issuer as 13,000 common shares via restricted stock units on 01/04/2024 and 6,500 common shares via performance stock units on 02/28/2025, with each acquisition listed as having an N/A nature of payment.

What prior KTOS share sales are reported in the past three months?

The notice reports 10b5-1 sales for Phillip Carrai of 6,000 KTOS common shares on 12/15/2025, generating $455,451.18 in gross proceeds during the past three months.

How many KTOS shares are outstanding according to this Form 144?

The filing states that there were 168,840,708 shares of KTOS common stock outstanding at the time referenced, which is provided as context for the planned sale.

Which broker is handling the planned KTOS Form 144 sale?

The planned sale of 19,500 KTOS common shares is listed as being handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, with trading on the NASDAQ exchange.

Does the KTOS Form 144 reference Rule 10b5-1 trading activity?

Yes. The section on securities sold during the past three months describes "10b5-1 Sales for PHILLIP CARRAI", reporting a sale of 6,000 common shares on 12/15/2025 for $455,451.18 in gross proceeds.